Don Kirkpatrick (L), Zach Sweeney and Nick Galli
After going down different drug discovery paths, Genentech vets reunite at Foresite Labs to map the 'protein interactome'
Throughout Zach Sweeney’s eight-year research stint at Roche/Genentech, one project stuck with him (quite literally): a program studying LRRK2.
Scientists knew early on there were …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
